These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 25081663)
1. Lack of effects of HER-2/neu on prognosis in colorectal cancer: a meta-analysis. Han J; Meng QY; Liu X; Xi QL; Zhuang QL; Wu GH Asian Pac J Cancer Prev; 2014; 15(14):5551-6. PubMed ID: 25081663 [TBL] [Abstract][Full Text] [Related]
2. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis. Wu SW; Ma CC; Li WH Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145 [TBL] [Abstract][Full Text] [Related]
3. HER-2 overexpression and survival in colorectal cancer: a meta-analysis. Li C; Liu DR; Ye LY; Huang LN; Jaiswal S; Li XW; Wang HH; Chen L J Zhejiang Univ Sci B; 2014 Jun; 15(6):582-9. PubMed ID: 24903996 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies. Wu SW; Ma CC; Yang Y Tumour Biol; 2014 Nov; 35(11):10799-804. PubMed ID: 25077923 [TBL] [Abstract][Full Text] [Related]
5. Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis. de Graeff P; Crijns AP; de Jong S; Boezen M; Post WJ; de Vries EG; van der Zee AG; de Bock GH Br J Cancer; 2009 Jul; 101(1):149-59. PubMed ID: 19513073 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of LGR5 in colorectal cancer: a meta-analysis. Chen Q; Zhang X; Li WM; Ji YQ; Cao HZ; Zheng P PLoS One; 2014; 9(9):e107013. PubMed ID: 25192390 [TBL] [Abstract][Full Text] [Related]
7. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis]. Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170 [No Abstract] [Full Text] [Related]
8. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis. Wang Y; Wang D; Ren M Tumour Biol; 2014 Jan; 35(1):33-8. PubMed ID: 23873100 [TBL] [Abstract][Full Text] [Related]
9. Effect of HER-2/neu over-expression on prognosis in gastric cancer: a meta-analysis. Wang S; Zheng G; Chen L; Xiong B Asian Pac J Cancer Prev; 2011; 12(6):1417-23. PubMed ID: 22229170 [TBL] [Abstract][Full Text] [Related]
10. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. He X; Chen Z; Jia M; Zhao X PLoS One; 2013; 8(7):e70858. PubMed ID: 23923027 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a systematic review and meta-analysis. Wang K; Guan C; Yu J; Jin X; Sun L; Zheng L; Xia L; Zhang Y Oncotarget; 2017 Sep; 8(43):75528-75543. PubMed ID: 29088888 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value and clinicopathological differences of HIFs in colorectal cancer: evidence from meta-analysis. Chen Z; He X; Xia W; Huang Q; Zhang Z; Ye J; Ni C; Wu P; Wu D; Xu J; Qiu F; Huang J PLoS One; 2013; 8(12):e80337. PubMed ID: 24324596 [TBL] [Abstract][Full Text] [Related]
13. The Prognostic and Predictive Value of Dihydropyrimidine Dehydrogenase-Related Indicators in Clinical Outcomes of Chemotherapy in Colorectal Cancer Patients: a Systematic Review and Meta-Analysis. Sun X; Guo S Pathol Oncol Res; 2020 Jan; 26(1):121-131. PubMed ID: 30519982 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of invariant chain (Ii) and Her-2/neu expression in curatively resected colorectal cancer. Rossi HA; Liu Q; Banner B; Hsieh CC; Savas L; Savarese D Cancer J; 2002; 8(3):268-75. PubMed ID: 12074327 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of HLA-G in patients with colorectal cancer: a meta-analysis and bioinformatics analysis. Zhang Y; He S; Yu L; Shi C; Zhang Y; Tang S BMC Cancer; 2023 Oct; 23(1):1024. PubMed ID: 37875821 [TBL] [Abstract][Full Text] [Related]
16. HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies. Zhang Q; Liu F; Wang B; Li Z; Zhou D; Yang Q; Dong J; Li J Medicine (Baltimore); 2016 Jun; 95(23):e3661. PubMed ID: 27281068 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor is a prognostic marker in patients with colorectal cancer: a meta-analysis. Huang CY; Zhou QY; Hu Y; Wen Y; Qiu ZW; Liang MG; Mo JL; Xu JH; Sun C; Liu FB; Chen XL Oncotarget; 2017 Apr; 8(14):23459-23469. PubMed ID: 28423584 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature. Peng L; Zhou Y; Wang Y; Mou H; Zhao Q PLoS One; 2013; 8(3):e58891. PubMed ID: 23527044 [TBL] [Abstract][Full Text] [Related]
19. HER-2/neu overexpression is an independent prognostic factor in colorectal cancer. Park DI; Kang MS; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Han WK; Kim H; Ryu SH; Sepulveda AR Int J Colorectal Dis; 2007 May; 22(5):491-7. PubMed ID: 16947041 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis. Shi M; Yu B; Gao H; Mu J; Ji C Mol Biol Rep; 2013 Jan; 40(1):617-23. PubMed ID: 23184003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]